Caplin Point Laboratories Limited
NSE: CAPLIPOINT.NS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- National Stock Exchange of India
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Sridhar Ganesan
- Employees
- 3,406
- Headquarters
- Chennai, India
- IPO year
- 2014
- Market cap
- ₹141.1B
- Website
- https://www.caplinpoint.net
Loading CAPLIPOINT…
Loading profile data…Frequently asked questions about CAPLIPOINT
What does Caplin Point Laboratories Limited (CAPLIPOINT.NS) do?
Caplin Point Laboratories Limited develops, produces, markets, and exports generic pharmaceutical formulations and branded products in India. The company provides liquid and lyophilized injections, ophthalmic products, tablets, liquid orals, capsules, softgel capsules, suppositories and ovules, powder for injection, dry syrups, topicals, inhaler...
Where does CAPLIPOINT.NS trade?
Caplin Point Laboratories Limited (CAPLIPOINT.NS) trades on the National Stock Exchange of India.
What sector is CAPLIPOINT.NS in?
Caplin Point Laboratories Limited (CAPLIPOINT.NS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Caplin Point Laboratories Limited?
Sridhar Ganesan is the chief executive officer of Caplin Point Laboratories Limited (CAPLIPOINT.NS).
Where is Caplin Point Laboratories Limited headquartered?
Caplin Point Laboratories Limited is headquartered in India.
Does CAPLIPOINT.NS pay a dividend?
Yes — Caplin Point Laboratories Limited (CAPLIPOINT.NS) paid a trailing twelve-month dividend of INR 6.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did CAPLIPOINT.NS go public?
Caplin Point Laboratories Limited (CAPLIPOINT.NS) completed its initial public offering in 2014.